Vivos Therapeutics says the FDA has cleared its oral device for severe obstructive sleep apnea, leading a massive rally in the company's shares before the bell.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
